acetylcysteine has been researched along with Small Cell Lung Carcinoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, CM; Han, DW; Ji, W; Lee, JC; Song, SY | 1 |
Jin, F; Liu, X; Ma, L; Wang, R; Weng, D; Yao, J | 1 |
2 other study(ies) available for acetylcysteine and Small Cell Lung Carcinoma
Article | Year |
---|---|
Efficacy of nebulized acetylcysteine for relieving symptoms and reducing usage of expectorants in patients with radiation pneumonitis.
Topics: Acetylcysteine; Adenocarcinoma; Administration, Inhalation; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Case-Control Studies; Expectorants; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Prospective Studies; Radiation Pneumonitis; Radiotherapy; Retrospective Studies; Small Cell Lung Carcinoma | 2019 |
Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway.
Topics: Acetylcysteine; Antineoplastic Agents; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Shape; Cell Survival; Cisplatin; Drug Screening Assays, Antitumor; Drug Synergism; Gallic Acid; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Membranes; Reactive Oxygen Species; Small Cell Lung Carcinoma | 2016 |